Schedule 13D ownership disclosure

VISTAGEN THERAPEUTICS INC

Security class unavailable · CUSIP: 92840H202

Event date: 2020-12-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-21-000001
Form type
SC 13D
Filer
Growth Equity Opportunities 17, LLC
CIK
CIK 1790256
Filed
Jan 04, 2021
Reporting period
Dec 22, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub